EQT Life Sciences — Full Portfolio

ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments.

BiotechHealthtechMedical Devices

Dr. Mark Throsby(Chief Executive Officer)

Co-investorsMRL Ventures FundV-Bio VenturesVIVES PartnersSambrinvestWallonie Entreprendre

Avidicure develops "Actibody", a triple-agonistic antibody platform built on a human IgG scaffold designed to activate the innate and adaptive immune system for treating oncology and autoimmune diseases.

AI & Machine LearningBiotech

Co-investorsBioGeneration VenturesBOMCurie CapitalKurma PartnersV-Bio Ventures

Egle Therapeutics develops targeted immunotherapy drugs by leveraging regulatory T cell (Treg) biology to treat autoimmune diseases and cancer.

Biotech

Fiorella Kotsias(Chief Scientific Officer)inBernard Vanhove(Chief Development Officer)in

BoardMichel Detheux(Chairman)in

Co-investorsFund+JDRF T1D Fund

Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.

BiotechHealthtechMedfield, US

Roger Heerman(Chief Business/Operating Officer / Co-Founder)inFrazer Morgan(Chief Development Officer / Co-Founder)Robert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)

BoardJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)

Co-investors5AM VenturesAtlas VentureRA CapitalSixty Degree CapitalVivo CapitalGimv+1 more

MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease.

BiotechHealthtech

PerBengt(CSO)

Co-investorsAdjuvant CapitalIndustrifondenOrbiMedPureos BioventuresSanofi VenturesSunstone Capital+2 more

Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure.

BiotechHealthtechMedical DevicesGhent, BE

Co-investorsNewton BiocapitalBlackRockKreos CapitalRosetta Capital Ltd.VI PartnersBootstrap Europe+2 more

VarmX develops VMX-C001, a therapeutic medicine for treating severe bleeding in patients on Factor Xa anticoagulants and for emergency surgery settings.

BiotechHealthtechMedical Devices

Pieter ReitsmaJohn Glasspool(Chief Executive Officer)

Co-investorsSound BioventuresYsios CapitalBioGeneration VenturesEICInkefUNIIQ+2 more

Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

Luc Dochez(Chair and Founder)Josh Mandel-Brehm(Co-Founder)

Co-investorsDroia VenturesKurma PartnersPureos BioventuresSeroba Life SciencesEurazeoIdinvest Partners

Evommune develops therapies targeting the underlying sources of chronic inflammatory diseases, aiming to provide underserved patient populations with more than symptomatic relief.

BiotechHealthtechPalo Alto, US

Luis Pena(Executive Officer, Director)inJanice Drew(Executive Officer)David Cohen(Director)Gregory Moss(Executive Officer)Eugene Bauer(Executive Officer, Director)Francois Beaubien(Director)

Board seatFelice Verduyn - Van Weegen· per SEC Form D · $115.5M raise · filed Jan 2025

Co-investorsAndera PartnersAvego BioScience CapitalB Capital GroupB4 CapitalBeiersdorf Innovation FundFemHealth Ventures+2 more

BiotechAmsterdam

Berndt Modig(Director)Dr. Robert Soiffer(Director)Otto Schwarz(Director)Subhanu Saxena(Director)Scott A. Holmes(Chief Financial Officer)James Joy(Executive Officer)

Board seatMartijn KleijwegtMark Wegter· per SEC Form D · $18.4M raise · filed Jun 2019

Lumeon provides an automated care orchestration platform that pulls data from health systems' care processes and existing systems and applies clinical intelligence to coordinate individualized patient care.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechBoston, US

Robbie Hughes(CEO and Founder)

Board seatRudy Dekeyser· per SEC Form D · $12M raise · filed Aug 2023

Co-investorsEndeavour VisionFraserOptum VenturesTechstarsAmadeus Capital Partners

1X is an AI and robotics company developing general-purpose humanoid robots for home and industrial use.

AI & Machine LearningConsumerHardwareRoboticsPalo Alto, US

Bernt Øyvind Børnich(CEO)Bernt Børnich(Founder)in

Co-investorsAlliance VCAlliance VentureEQT VenturesSamsung NextSandwaterSkagerak Capital+8 more

Co-investorsAndera PartnersCTI Life Sciences Fund L.P.Kurma PartnersLSP (Life Sciences Partners)Sofinnova Partners

Atalanta is a mathematical AI company that provides software verification and formal methods capabilities to ensure provably correct decision-making in complex systems for high-stakes missions in energy, space, and defense sectors.

AI & Machine LearningDeep TechDefense Tech

Jonathan Ring(Founder)in

Co-investorsFelicis Venturesabrdn plcF-Prime Capital

Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology.

BiotechDeep TechHealthtechMedical Devices

Co-investorsF-Prime CapitalNovartis Venture FundRiverVest Venture PartnersSanofi Venturesabrdn plc

Cambridge Vision Technology develops diagnostic hardware and software for detecting Alzheimer's disease and other neurodegenerative conditions through retinal imaging and biomarker analysis.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, US

Developer of the EmboTrap stroke treatment device for removing clots from the brain; acquired by Johnson & Johnson.

Co-investorsLSP (Life Sciences Partners)Western Development Commission

Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients.

HealthtechMedical Devices

Co-investorsAtlantic Bridge VenturesEnterprise IrelandFountain Healthcare PartnersWestern Development Commission

Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.

BiotechHealthtechMedical DevicesAliso Viejo, US

David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)

BoardJoyce Erony(Director)inWilliam Harrington(Director)

Co-investorsAmzak HealthAPERTURE Venture PartnersCWRU Technology VenturesiSelect FundJobsOhio VenturesJumpstart Ventures+5 more

NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions.

BiotechHealthtechMedical Devices

Co-investorsBain Capital Life SciencesFrazier Life SciencesLSP (Life Sciences Partners)

Nobi manufactures intelligent lamps equipped with optical sensors and artificial intelligence to detect falls and monitor health for elderly care in residential facilities and home settings.

AI & Machine LearningHealthtechIoT

Co-investors15th RockAngelini VenturesPMV

Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs.

BiotechHealthtechMedical Devices

Ilise Lombardo(Chief Executive Officer)inVolker Knappertz(Executive Vice President of Research & Development)inMichael Samar(Chief Financial Officer)inRob Lasser(Chief Medical Officer)in

Co-investorsBioMedPartnersJeito CapitalRoche Venture FundSofinnova PartnersEQTForbion+2 more

Onera Health provides clinical-grade remote diagnostics and monitoring solutions for healthcare professionals, with an initial focus on sleep health.

Digital HealthHealthtechMedical DevicesEindhoven, NL

Co-investors15th RockLSP (Life Sciences Partners)imec.xpandInnovation Industries

PanTera develops actinium-225, a therapeutic radioisotope used in precision cancer treatment through radiotheranostics, serving oncology patients and pharmaceutical companies globally.

BiotechDeep TechHealthtechMedical DevicesMol, BE

Sven van den berghe(CEO)Christophe Malice(CBO)Samy Bertrand(CTO)Yves Sterckx(Director of Finance & Administration)Philippe Vanwolleghem(Director Quality, Regulatory Affairs & HSE)

Co-investorsKorysKurma PartnersLSP (Life Sciences Partners)PMV

Payrails provides a modular financial operating system for enterprises that manages payment and financial workflows.

Enterprise SoftwareFintechSaaSBerlin, DE

Emre Talay(Founder)inNicolas Thouzeau(Founder)Orkhan Abdullayev(Founder)

Co-investorsAndreessen HorowitzDeBa VenturesEQT VenturesGeneral Catalyst

QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.

BiotechDeep TechMedical DevicesCambridge, US

Kevin Eggan(Co-founder)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Director, Executive Officer, Promoter)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in

Co-investorsDroia VenturesMC Healthcare VenturesMission BiocapitalMitsui Global InvestmentSanofi VenturesSV Health Investors+6 more

Sana is an AI lab that develops agentic AI systems to help teams access knowledge, automate repetitive work, and learn.

AI & Machine LearningEnterprise SoftwareFuture of WorkStockholm, SE

Co-investorsAcequia Capital (AceCap)EQT VenturesLeksell Social VenturesMenlo VenturesNew Enterprise Associates (NEA)Workday Ventures

SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.

BiotechDeep TechDigital HealthBarcelona, ES

Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)

Co-investorsNovartis Venture FundRoche Venture FundSanofi VenturesYsios CapitalAsabys PartnersCriteria Bio Ventures+2 more

Co-investorsatai Life SciencesAtaiBeckleyICONIQMaRS

Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology.

BiotechDeep TechHealthtechMedical Devices

Eliane Schutte(Chief Executive Officer)

Co-investorsKurma PartnersVI PartnersYsios CapitalInvest-NL